Medtronic GuardWire Begins Controlled Roll-Out In U.S. Market
This article was originally published in The Gray Sheet
Executive Summary
Medtronic PercuSurge is planning to submit an IDE application in the next two months for a 500-600 patient trial evaluating its GuardWire distal protection device in patients with acute myocardial infarction.